Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains ...

Add Yahoo as a preferred source to see more of our stories on Google. Wegovy and other injectable weight-loss medications have soared in popularity in the past two years. Supply issues and spotty ...

Compounded semaglutide, meanwhile, contains the same active ingredient as Ozempic, semaglutide. However, this medication is not approved by the FDA, and it may pose risks to those who take it, ...

Mon, February 10, 2025 at 4:52 AM UTC Some call these medications “generic Ozempic” (they’re not); others, “fake Ozempic” (nope, except when the ads are for illegal or nonexistent drugs). And last ...

When Tina Jacobson tried to get Ozempic to lose weight, her health insurance provider denied coverage because she was not diabetic. Instead of paying more than $1,000 out of pocket for the Type 2 ...

Compounded forms of semaglutide and tirzepatide were being sold by dozens of compounded pharmacies from August to October ...

A secret shopper survey conducted by researchers at Yale University and published this week in the Journal of the American Medical Association offers an alarming, if unsurprising, glimpse into the ...

Tirzepatide is a dual GLP-1 and GIP receptor agonist that mimics two hormones in the gut that help regulate blood sugar, reduce hunger cues and slow digestion. It’s the active ingredient in the ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Patients are being hospitalized with severe complications after ...

The decision to prescribe a compounded or brand-name glucagon-like peptide 1 (GLP-1) medication for obesity treatment was never simple, but recent developments have complicated it further. In the ...

By Nqobile Dludla JOHANNESBURG, July 14 (Reuters) - South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its production of compounded weight-loss ...